Hepatic functional reserve in patients with biliary malignancies: An assessment by technetium 99m galactosyl human serum albumin hepatic scintigraphy

International Surgery

Volumn 84, Issue 3, 1999, Pages 199-203

  Fukunaga, Kiyoshi ^a   Todoroki, Takeshi ^b   Takada, Yasutsugu ^b   Otsuka, Masaaki ^b   Kawamoto, Toru ^b   Fukao, Katashi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

Biliary malignancy; Bilirubin half life; Hepatic functional reserve; Jaundice; Technetium 99m galactosyl human serum albumin

Indexed keywords

DIAGNOSTIC AGENT; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA GALACTOSYL HUMAN SERUM ALBUMIN; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; FEMALE; GALLBLADDER TUMOR; HUMAN; LIVER; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

ADULT; AGED; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; LIVER; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 0033155431     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983; 139: 217-38
2. Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223: 384-94
3. Moody FG, Rikkers LF, Aldrete JS. Estimation of the functional reserve of human liver. Ann Surg 1974; 180: 592-8
4. Paumgartner G. The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975; 105 Suppl 17: 1-30
5. Blamey SL, Fearon KCH, Girmour WH, Osborne DH, Carter DC. Prediction of risk in biliary surgery. Br J Surg 1983; 70: 536-8
6. Dixon JM, Armstrong CP, Duffy SW, Davies GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 1983; 24: 845-52
7. Lacaine F, Fourtanier G, Fingerhut A, Hay JM. Surgical mortality and morbidity in malignant obstructive jaundice: a prospective multivariate analysis. Eur J Surg 1995; 161: 729-34
8. Pitt HA, Cameron JL, Postier RG, Gadacz TR. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141: 66-72
9. McPherson GAD, Benjamin IS, Boobies AR, Blumgart LH. Antipyrine elimination in patients with obstructive jaundice: a predictor of outcome. Am J Surg 1985; 149: 140-3
10. Tsubono T, Tsukda K, Hatakeyama K. Hepatic functional reserve in patients with obstructive jaundice: an assessment by the redox tolerance test. Am J Surg 1995; 169: 300-3
11. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. Radiology 1984; 151: 196-7
12. Koizumi K, Uchiyama G, Arai T, Ainoda T, Yoda Y. A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: evaluation of the validity of several functional parameters. Ann Nucl Med 1992; 6: 83-7
13. 99mTechnetium galactosyl serum albumin. Hepatogastroenterology 1993; 40: 32-6
14. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99m diethylenetriaminepentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 1995; 117: 429-34
15. Stockert RJ, Gärtner U, Morell AG, Wolkoff AW. Effect of receptor-specific antibody on the uptake of desialylated glycoproteins in the isolated perfused rat liver. J Biol Chem 1980; 255: 3830-1
16. 99mTc-GSA, a new agent for functional imaging of the liver. Jpn J Nucl Med 1992; 29: 159-79
17. Little JM, Robotin M. Serum bilirubin after surgery for obstructive jaundice. Aust N Z J Surg 1986; 56: 35-7
18. Shimizu T, Yoshida K, Muto T. Classification of obstructive jaundice based on the bilirubin decreasing rate 'b' and its clinical significance. J Jpn Surg Soc 1979; 80: 93-7
19. Beahrs OH, Henson DE, Hunter RVP, Myers MH, American Joint Committee on Cancer. Manual for staging of cancer, 3rd edn. Philadelphia, Lippincott, 1988
20. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-8
21. Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128: 871-9
22. Gregoriadis G, Morell AG, Sternlieb I, Scheinberg H. Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem 1970; 245: 5833-7
23. Kamiike W, Nakahara M, Nakao K, Koseki M, Nishida T, Kawashima Y et al. Correlation between cellular ATP level and bile excretion in the rat liver. Transplantation 1985; 39: 50-5
24. Karwinski W, Husoy AM, Farstad M, Soreide O. Sixty minutes of normothermic ischemia in the rat liver: correlation between adenine nucleotides and bile excretion. J Surg Res 1989; 46: 99-103
25. Tanaka J, Ozawa K, Tobe T. Significance of blood ketone body ratio as an indicator of hepatic cellular energy status in jaundiced rabbits. Gastroenterology 1979; 76: 691-6
26. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11: 49-53
27. Canalese J, Gove CD, Gimson AES, Wilkinson SP, Wardle EN, Williams R. Reticuloendothelial system and hepatocyte function in fulminant hepatic failure. Gut 1982; 23: 265-9
28. Watanabe A, Shiota T, Higashi T. Multiple organ failure in patients with fulminant hepatitis and in post-operative patients with liver cirrhosis. J Med 1992; 23: 117-25